Global Medical Devices Reimbursement Market 2023-2029
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global medical devices reimbursement market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors approaches.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the payers, healthcare setting, and region. The global market for medical devices reimbursement can be segmented by payers: public, private. The private segment captured the largest share of the market in 2022. Medical devices reimbursement market is further segmented by healthcare setting: hospitals, outpatient facilities, others. The hospitals segment held the largest share of the global medical devices reimbursement market in 2022 and is anticipated to hold its share during the forecast period. Based on region, the medical devices reimbursement market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. In 2022, North America made up the largest share of revenue generated by the medical devices reimbursement market.
Market Segmentation
By payers: public, private
By healthcare setting: hospitals, outpatient facilities, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The report also provides a detailed analysis of several leading medical devices reimbursement market vendors that include Aetna Inc., Allianz SE, Anco Insurance Managers, Ltd., Aviva plc, BNP Paribas SA, Centene Corporation, Cigna Corporation, CVS Health Corporation, Elevance Health, Inc., Hamilton Leigh Limited, HUB International Limited, Humana Inc., Nippon Life Insurance Company, North American Science Associates, Inc. (NAMSA), ProAssurance Corporation (Medmarc Insurance Group), Reliance Nippon Life Insurance Company Limited, UnitedHealth Group Incorporated, WellCare Health Plans, Inc., Xifin, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Scope of the Report
To analyze and forecast the market size of the global medical devices reimbursement market.
To classify and forecast the global medical devices reimbursement market based on payers, healthcare setting, region.
To identify drivers and challenges for the global medical devices reimbursement market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global medical devices reimbursement market.
To identify and analyze the profile of leading players operating in the global medical devices reimbursement market.
Why Choose This Report
Gain a reliable outlook of the global medical devices reimbursement market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
PART 5. MARKET BREAKDOWN BY PAYERS
Public
Private
PART 6. MARKET BREAKDOWN BY HEALTHCARE SETTING
Hospitals
Outpatient facilities
Others
PART 7. MARKET BREAKDOWN BY REGION
North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America
PART 8. KEY COMPANIES
Aetna Inc.
Allianz SE
Anco Insurance Managers, Ltd.
Aviva plc
BNP Paribas SA
Centene Corporation
Cigna Corporation
CVS Health Corporation
Elevance Health, Inc.
Hamilton Leigh Limited
HUB International Limited
Humana Inc.
Nippon Life Insurance Company
North American Science Associates, Inc. (NAMSA)
ProAssurance Corporation (Medmarc Insurance Group)
Reliance Nippon Life Insurance Company Limited
UnitedHealth Group Incorporated
WellCare Health Plans, Inc.
Xifin, Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Global Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations
Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The
USD 7500 View Report2024 Global PSA Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Opportunities
2024 Global PSA Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities This unique report from provides information and analysis not available from any
USD 2450 View ReportGlobal Medical Injection Molded Plastics Market 2023
Medical injection molded plastics are used in the manufacturing of various medical devices and components, such as syringes, vials, IV components, and other disposable medical products. These plastics are designed
USD 2750 View ReportGlobal Medical Device Coatings Market 2023
The global medical device coatings market is projected to reach USD 15.58 billion by 2029, with a CAGR of 4.8% from 2023 to 2029. Market growth is driven by the
USD 2950 View ReportFill The Form For Sample Request